TORNTPHARM

Torrent Pharmaceuticals Ltd is the flagship company of the Torrent Group, engaged in the research, development, manufacturing, and marketing of generic pharmaceutical formulations. Its operations cover specialty-driven pharmaceutical markets with a focus on chronic and sub-chronic therapies, which account for approximately 76% of its revenues in India. The company operates in the pharmaceuticals, power, and city gas distribution industries and offers products including cardiovascular drugs, central nervous system drugs, gastrointestinal drugs, and vitamins, minerals, and nutrients. Torrent Pharmaceuticals has a global presence with operations in India, Brazil, and Germany. It runs eight manufacturing facilities, five of which are approved by the USFDA, and maintains a dedicated R&D center staffed by over 750 scientists.